These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

156 related articles for article (PubMed ID: 21303355)

  • 1. Microparticles, malignancy and thrombosis.
    Zahra S; Anderson JA; Stirling D; Ludlam CA
    Br J Haematol; 2011 Mar; 152(6):688-700. PubMed ID: 21303355
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Microparticles and thrombotic disease.
    Davizon P; López JA
    Curr Opin Hematol; 2009 Sep; 16(5):334-41. PubMed ID: 19606028
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Clinical significance of circulating microparticles for venous thromboembolism in cancer patients.
    Thaler J; Ay C; Pabinger I
    Hamostaseologie; 2012; 32(2):127-31. PubMed ID: 21792463
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Membrane microparticles in VTE and cancer.
    Key NS; Chantrathammachart P; Moody PW; Chang JY
    Thromb Res; 2010 Apr; 125 Suppl 2():S80-3. PubMed ID: 20434013
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Circulating microparticles remain associated with complement activation despite intensive anti-inflammatory therapy in early rheumatoid arthritis.
    van Eijk IC; Tushuizen ME; Sturk A; Dijkmans BA; Boers M; Voskuyl AE; Diamant M; Wolbink GJ; Nieuwland R; Nurmohamed MT
    Ann Rheum Dis; 2010 Jul; 69(7):1378-82. PubMed ID: 19919943
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Circulating procoagulant microparticles in cancer patients.
    Thaler J; Ay C; Weinstabl H; Dunkler D; Simanek R; Vormittag R; Freyssinet JM; Zielinski C; Pabinger I
    Ann Hematol; 2011 Apr; 90(4):447-53. PubMed ID: 20981426
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Microparticles and female issues].
    Toth B
    Hamostaseologie; 2009 Jan; 29(1):46-50. PubMed ID: 19151846
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Microparticles: Bridging the Gap between Autoimmunity and Thrombosis.
    Niccolai E; Emmi G; Squatrito D; Silvestri E; Emmi L; Amedei A; Prisco D
    Semin Thromb Hemost; 2015 Jun; 41(4):413-22. PubMed ID: 25965903
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Involvement of platelet-derived microparticles in tumor progression and thrombosis.
    Mezouar S; Mege D; Darbousset R; Farge D; Debourdeau P; Dignat-George F; Panicot-Dubois L; Dubois C
    Semin Oncol; 2014 Jun; 41(3):346-58. PubMed ID: 25023350
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Microparticle analysis in disorders of hemostasis and thrombosis.
    Mooberry MJ; Key NS
    Cytometry A; 2016 Feb; 89(2):111-22. PubMed ID: 25704723
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Circulating tissue factor-exposing microparticles.
    Lechner D; Weltermann A
    Thromb Res; 2008; 122 Suppl 1():S47-54. PubMed ID: 18691500
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Microparticles in health and disease.
    Enjeti AK; Lincz LF; Seldon M
    Semin Thromb Hemost; 2008 Oct; 34(7):683-91. PubMed ID: 19085769
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Microparticles, thrombosis and cancer.
    Aharon A; Brenner B
    Best Pract Res Clin Haematol; 2009 Mar; 22(1):61-9. PubMed ID: 19285273
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The role of microparticles in inflammation and thrombosis.
    Ardoin SP; Shanahan JC; Pisetsky DS
    Scand J Immunol; 2007; 66(2-3):159-65. PubMed ID: 17635793
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Pathophysiologic significance of procoagulant microvesicles in cancer disease and progression.
    Castellana D; Kunzelmann C; Freyssinet JM
    Hamostaseologie; 2009 Jan; 29(1):51-7. PubMed ID: 19151847
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Tissue factor procoagulant activity of plasma microparticles is increased in patients with early-stage prostate cancer.
    Haubold K; Rink M; Spath B; Friedrich M; Chun FK; Marx G; Amirkhosravi A; Francis JL; Bokemeyer C; Eifrig B; Langer F
    Thromb Haemost; 2009 Jun; 101(6):1147-55. PubMed ID: 19492160
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cancer-associated thrombosis.
    Zwicker JI; Furie BC; Furie B
    Crit Rev Oncol Hematol; 2007 May; 62(2):126-36. PubMed ID: 17293122
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Placenta-derived microparticles.
    Aharon A; Brenner B
    Thromb Res; 2013 Jan; 131 Suppl 1():S22-4. PubMed ID: 23452734
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Flow cytometric analysis of cell membrane microparticles.
    Gelderman MP; Simak J
    Methods Mol Biol; 2008; 484():79-93. PubMed ID: 18592174
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Function and role of microparticles in various clinical settings.
    Nomura S; Ozaki Y; Ikeda Y
    Thromb Res; 2008; 123(1):8-23. PubMed ID: 18667228
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.